|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics显示文摘Hepatitis B virus reactivation(HBVr)can occur in patients treated with immunosuppressive medications.Risk stratification for HBVr based on hepatitis B virus(HBV)serology and viral load is an important strategy to determine appropriate HBV monitoring and antiviral prophylaxis use.Recent advances in the understanding of pathophysiology of autoimmune diseases have led the development of cytokine-targeted therapies.Tumor necrosis factor(TNF)-αinhibitors have been widely used for patients with inflammatory bowel disease,psoriasis,and rheumatic diseases.Further,the clinical benefits of interleukin(IL)-12/23,IL-17,or Janus kinases inhibitors have been demonstrated in these patients.It is well known that TNF-αinhibitor use can lead to HBVr,however,the risk of HBVr in patients undergoing non-TNF-targeted biologics have not been fully understood.In this review,we discuss the risk of HBVr in patients treated with non-TNF-targeted biologics,and immunological mechanisms of these medications causing HBVr. | Shintaro Akiyama Thomas G Cotter Atsushi Sakuraba | 2021 | World Journal of Gastroenterology2021，27，19： | 4 |
| 2 | Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli 显示文摘 | LENNON S V MARTIN S J COTTER T G | 1991 | Cell Prolif1991，24，2： | 1 |
| 3 | Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure显示文摘 | Cotter G Kiowski W Kaluski E | 2001 | Eur J Heart Fail2001，3，4： | 1 |
| 4 | Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial显示文摘 | John R Teerlink Gad Cotter Beth A Davison G Michael Felker Gerasimos Filippatos Barry H Greenberg Piotr Ponikowski Elaine Unemori Adriaan A Voors Kirkwood F Adams Maria I Dorobantu Liliana R Grinfeld Guillaume Jondeau Alon Marmor Josep Masip Peter S Pang | 2013 | The Lancet . 2013 (9860)2013，，9860： | 1 |
| 5 | Structure of Very High Thermal Conductance显示文摘 | Grover G M Cotter T P Erikson G F | | 0，，06： | 1 |
| 6 | Serelaxin,recombinant human relaxin-2,for treatment of acute heart failure(RELAX-AHF):a randomised,placebo-controlled trial显示文摘 | TEERLINK J R COTTER G DAVISON B A | 2013 | Lancet2013，381，： | 1 |
| 7 | The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure显示文摘 | Schalcher C Cotter G Reisin L | 2001 | Am Heart J2001，142，2： | 1 |
| 8 | Apoptosis:A potential therapeutic target for retinal degenerations显示文摘 | Doonan F Cotter T G | 2004 | Curr Neurov Res2004，1，1： | 1 |
| 9 | The PROTECT pilot stud- y : a randomized, placebocontlvlled, dose - finding study of the adeno- sine A1 receptor antagonist rolofylline in patients with acute heart fail- ure and renal impairment 显示文摘 | Cotter G Dittrich HC Weatherley BD | 2008 | J Calxl Fail2008，14，： | 1 |
| 10 | MCMC methods for functions:modifying old algorithms to make them faster显示文摘 | COTTER S L ROBERTS G O STUART A M | 2013 | Statistical Science2013，28，3： | 1 |
| 11 | L-NMMA (a nitric oxide synthase inhibitor)is effective in the treatment of cardiogenic shock显示文摘 | Cotter G Kaluski E Blatt A | 2000 | Circulation2000，101，： | 1 |
| 12 | Lincs:L-NAME(a NO synthase inhibitor) in the treatment of refractory cardiogenic shock:a prospective randomized study显示文摘 | Cotter G Kalushi E Milo O | 2003 | Eur Heart J2003，24，14： | 1 |
| 13 | The role of the kidney in heart failure显示文摘 | Metra M Cotter G Gheorghiade M | 2012 | Eur Heart J2012，33，17： | 1 |
| 14 | Industrial Diamond Substitutes Ⅰ:Physical and X-ray Study of Hafnium Carbide显示文摘 | COTTER P G KOHN J A | | 0，，： | 1 |
| 15 | Serelaxin,recombinant human relaxin-2,for treatment of acute heart failure(RELAX-AHF):a randomised,placebo-controlled trial显示文摘 | Teerlink JR Cotter G Davison BA | | 0，，9860： | 1 |
| 16 | Lack of aspirin effect : aspirin resistance or resistance to taking aspirin? 显示文摘 | Cotter G Shemesh E Zehavi M | 2004 | Am Heart J2004，147，2： | 1 |
| 17 | Effect of serelaxin on cardiac,renal,and hepatic biomarkers in the Relaxin in Acute Heart Failure(RELAX-AHF)development program:correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | | 0，，02： | 1 |
| 18 | 显示文摘 | Cotter D Burt M G Manning R J | 1992 | Phys Rew Lett1992，68，8： | 1 |
| 19 | High-dose nitrates in the immediate management of unstable angina:optimal dosage,route of administration,and therapeutic goals显示文摘 | Cotter G Faibel H Barash P | | 0，，： | 1 |
| 20 | Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF) : a randomised, placebo-controlled trial显示文摘 | TeerlinkJR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员